GRI
Price:
$1.88
Market Cap:
$168.88K
GRI Bio, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutic agents within the United States. Its primary focus lies in addressing inflammatory, fibrotic, and autoimmune disorders. The company's leading drug candidate is GRI-0621, an oral inhibitor targeting type 1 Natural Killer T cells, which is currently undergoing Phase IIa clinical trials. This investigational treatment is being evaluated for severe fibrotic lung conditions, including idiopathic pulmonary fibrosis. Beyond its flagship program, GRI Bio's pipeline also features GRI-0803, a novel oral agonist designed to activate type 2 Natural Killer T cells, cur...[Read more]
Industry
Biotechnology
IPO Date
2023-04-24
Stock Exchange
NASDAQ
Ticker
GRI
According to GRI Bio, Inc.’s latest financial reports and current stock price. The company's current ROE is -199.52%. This represents a change of 150.34% compared to the average of -79.70% of the last 4 quarters.
The mean historical ROE of GRI Bio, Inc. over the last ten years is -974.35%. The current -199.52% ROE has changed -79.52% with respect to the historical average. Over the past ten years (40 quarters), GRI's ROE was at its highest in in the September 2020 quarter at 4.35%. The ROE was at its lowest in in the January 2024 quarter at -773.75%.
Average
-974.35%
Median
-153.40%
Minimum
-5033.59%
Maximum
197.97%
Discovering the peaks and valleys of GRI Bio, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 13.13%
Maximum Annual ROE = 197.97%
Minimum Annual Increase = -2642.61%
Minimum Annual ROE = -5033.59%
| Year | ROE | Change |
|---|---|---|
| 2025 | -199.00% | -2.23% |
| 2024 | -203.55% | -95.96% |
| 2023 | -5033.59% | -2642.61% |
| 2022 | 197.97% | 0.53% |
| 2021 | 196.93% | 13.13% |
| 2020 | 174.07% | -261.48% |
| 2019 | -107.80% | -96.18% |
The current ROE of GRI Bio, Inc. (GRI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1812.05%
5-year avg
-1008.25%
10-year avg
-974.35%
GRI Bio, Inc.’s ROE is greater than CNS Pharmaceuticals, Inc. (-238.69%), less than Jaguar Health, Inc. (764.53%), greater than Silo Pharma, Inc. (-88.41%), greater than Biodexa Pharmaceuticals Plc (-55.81%), less than Abpro Corporation (73.51%), greater than InMed Pharmaceuticals Inc. (-72.72%), greater than Can-Fite BioPharma Ltd. (-141.01%), greater than 60 Degrees Pharmaceuticals, Inc. (-200.17%), greater than Genprex, Inc. (-247.33%), greater than Calidi Biotherapeutics, Inc. (-438.03%),
| Company | ROE | Market cap |
|---|---|---|
| -238.69% | $2.70M | |
| 764.53% | $149.94K | |
| -88.41% | $5.54M | |
| -55.81% | $2.28M | |
| 73.51% | $1.06M | |
| -72.72% | $2.70M | |
| -141.01% | $1.60M | |
| -200.17% | $1.32M | |
| -247.33% | $966.05K | |
| -438.03% | $1.24M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GRI Bio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like GRI Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is GRI Bio, Inc.'s ROE?
How is the ROE calculated for GRI Bio, Inc. (GRI)?
What is the highest ROE for GRI Bio, Inc. (GRI)?
What is the 3-year average ROE for GRI Bio, Inc. (GRI)?
What is the 5-year average ROE for GRI Bio, Inc. (GRI)?
How does the current ROE for GRI Bio, Inc. (GRI) compare to its historical average?